Forgot your password?

Forgot your username?

database > company
CytRx
Biotech Specialty Pharma
11726 San Vicente Blvd., Suite 650
Los Angeles, CA 90049 USA
phone:phone
fax:fax
Click for website
Research Sector Biotech Specialty Pharma
Summary Description
Biopharmaceutical research and development company engaged in the development of human therapeutics.
Click here for Financial Data
Keywords
tamibarotene, bafetinib, arimoclomol, iroxanadine, proteins, RNAi, cancer,



Description

CytRx is a biopharmaceutical research and development company engaged in the development of human therapeutics.......view more

Products / Services

CytRx Corporation is a biopharmaceutical research and development company engaged in the development of high-value human therapeutics. The CytRx drug development pipeline includes tamibarotene which i......view more


Technology / Differentiation

CytRx has several proprietary anti-cancer drug candidates in development. INNO-206 incorporates a unique acid-sensitive linker technology that allows for improved targeting to the tumor. This result...view more

Market / Customers

CytRx is developing drugs for various forms of cancer. Tamibarotene and bafetinib are being developed to treat different types of leukemias. INNO-206 has a linker technology for the treatment of sol......view more


Competitors / Substitutes / Alternatives

Celgene Corporation, Cephalon, Sanofi-Aventis...view more


Status

CytRx�s lead compound Tamibarotene is in a pivotal phase 2 clinical trial with a Special Protocol Assessment with the FDA. The trial targets 3rd line APL. A phase 1/2 clinical trial with Tamibarot...view more



2014-08-01-2295